[
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=dd438ed5070e5eebe7e58ebe397791d947e14d2bfba9251e8835c003ed9ee8a5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737650100,
      "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "id": 132460950,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=dd438ed5070e5eebe7e58ebe397791d947e14d2bfba9251e8835c003ed9ee8a5"
    }
  },
  {
    "ts": null,
    "headline": "Valneva Is A 'Buy' As A First-Mover In Chikungunya",
    "summary": "Valnevaâs growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term outlook despite near-term challenges.",
    "url": "https://finnhub.io/api/news?id=e87fa972abe5c23c4ae32f2e8501fc3b58bee6c081cfa2dd043fedf5966d8833",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737647328,
      "headline": "Valneva Is A 'Buy' As A First-Mover In Chikungunya",
      "id": 132450347,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1316007813/image_1316007813.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Valnevaâs growth potential lies in Ixchiq, but risks remain. Find out why VALN stock is still a Buy with a good long-term outlook despite near-term challenges.",
      "url": "https://finnhub.io/api/news?id=e87fa972abe5c23c4ae32f2e8501fc3b58bee6c081cfa2dd043fedf5966d8833"
    }
  },
  {
    "ts": null,
    "headline": "AstraZeneca's Growth Potential: 6 Reasons For A Buy Rating",
    "summary": "AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the companyâs future looks bright.",
    "url": "https://finnhub.io/api/news?id=b0bffa5a9ae5c47a255e185aa2cf65897e628d26de0c5f6cfe30db3a2a88b556",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737639382,
      "headline": "AstraZeneca's Growth Potential: 6 Reasons For A Buy Rating",
      "id": 132449871,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/107429764/image_107429764.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the companyâs future looks bright.",
      "url": "https://finnhub.io/api/news?id=b0bffa5a9ae5c47a255e185aa2cf65897e628d26de0c5f6cfe30db3a2a88b556"
    }
  },
  {
    "ts": null,
    "headline": "SCHD: Kick Back And Let The Good Times Roll",
    "summary": "The Schwab U.S. Dividend Equity ETF offers automatic diversification, income, and growth. Read what makes SCHD a solid investment choice.",
    "url": "https://finnhub.io/api/news?id=970d51467dc333e1d03500f6dc1f64033604b37bd1838d8e5ccc71d45e33149a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737619200,
      "headline": "SCHD: Kick Back And Let The Good Times Roll",
      "id": 132448304,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/692898906/image_692898906.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "The Schwab U.S. Dividend Equity ETF offers automatic diversification, income, and growth. Read what makes SCHD a solid investment choice.",
      "url": "https://finnhub.io/api/news?id=970d51467dc333e1d03500f6dc1f64033604b37bd1838d8e5ccc71d45e33149a"
    }
  },
  {
    "ts": null,
    "headline": "How To Invest $100,000 In The Ten Cheapest Dow Dividend 100 Stocks",
    "summary": "SCHD is one of my favorite dividend funds. Check out the Top 20 holdings of SCHD and score them according to which, I believe, are the top 10 cheapest of the lot.",
    "url": "https://finnhub.io/api/news?id=7986981a49e059c451440c17aa615ffa1b9d38e9d37b2b0a7a28b252e7b8ab60",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1737605869,
      "headline": "How To Invest $100,000 In The Ten Cheapest Dow Dividend 100 Stocks",
      "id": 132447070,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "SCHD is one of my favorite dividend funds. Check out the Top 20 holdings of SCHD and score them according to which, I believe, are the top 10 cheapest of the lot.",
      "url": "https://finnhub.io/api/news?id=7986981a49e059c451440c17aa615ffa1b9d38e9d37b2b0a7a28b252e7b8ab60"
    }
  }
]